Table 1. Clinical characteristics of 3 patients with fulminant type 1 diabetes in seromic analysis.

							Duration
	Age	Gender	HbA1c	HbA1c	Glucose	GAD/IA-2	of diabetes
	(years)*	(m/f)†	(%)	(mmol/mol)	(mg/dl)*	antibody	(days)#
Case 1	57	m	6.9	51.9	1275	−/−	8/40
Case 2	64	m	7.6	59.5	1015	−/−	2/32
Case 3	25	f	5.9	41.0	589	−/−	3/28

*at onset

†m/f; male/female

#acute/sub-acute phase